Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt N/A
MDRX's Cash-to-Debt is ranked lower than
95% of the 1930 Companies
in the Global Software - Application industry.

( Industry Median: 8.51 vs. MDRX: N/A )
Ranked among companies with meaningful Cash-to-Debt only.
MDRX' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.07  Med: 0.57 Max: No Debt
Current: N/A
Equity-to-Asset 0.35
MDRX's Equity-to-Asset is ranked lower than
80% of the 1831 Companies
in the Global Software - Application industry.

( Industry Median: 0.61 vs. MDRX: 0.35 )
Ranked among companies with meaningful Equity-to-Asset only.
MDRX' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.3  Med: 0.59 Max: 0.95
Current: 0.35
0.3
0.95
Interest Coverage 1.20
MDRX's Interest Coverage is ranked lower than
94% of the 1543 Companies
in the Global Software - Application industry.

( Industry Median: 180.58 vs. MDRX: 1.20 )
Ranked among companies with meaningful Interest Coverage only.
MDRX' s Interest Coverage Range Over the Past 10 Years
Min: 0.82  Med: 5.97 Max: 52.48
Current: 1.2
0.82
52.48
WACC vs ROIC
5.39%
0.95%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 3.86
MDRX's Operating Margin % is ranked higher than
50% of the 1869 Companies
in the Global Software - Application industry.

( Industry Median: 4.79 vs. MDRX: 3.86 )
Ranked among companies with meaningful Operating Margin % only.
MDRX' s Operating Margin % Range Over the Past 10 Years
Min: -9.29  Med: 6.12 Max: 14.84
Current: 3.86
-9.29
14.84
Net Margin % -1.66
MDRX's Net Margin % is ranked lower than
64% of the 1869 Companies
in the Global Software - Application industry.

( Industry Median: 3.13 vs. MDRX: -1.66 )
Ranked among companies with meaningful Net Margin % only.
MDRX' s Net Margin % Range Over the Past 10 Years
Min: -7.58  Med: 2.33 Max: 8.92
Current: -1.66
-7.58
8.92
ROE % -1.88
MDRX's ROE % is ranked lower than
65% of the 1820 Companies
in the Global Software - Application industry.

( Industry Median: 6.06 vs. MDRX: -1.88 )
Ranked among companies with meaningful ROE % only.
MDRX' s ROE % Range Over the Past 10 Years
Min: -7.99  Med: 2.46 Max: 8.34
Current: -1.88
-7.99
8.34
ROA % -0.83
MDRX's ROA % is ranked lower than
61% of the 1936 Companies
in the Global Software - Application industry.

( Industry Median: 2.84 vs. MDRX: -0.83 )
Ranked among companies with meaningful ROA % only.
MDRX' s ROA % Range Over the Past 10 Years
Min: -4.19  Med: 1.68 Max: 6.14
Current: -0.83
-4.19
6.14
ROC (Joel Greenblatt) % 26.58
MDRX's ROC (Joel Greenblatt) % is ranked higher than
59% of the 1896 Companies
in the Global Software - Application industry.

( Industry Median: 22.22 vs. MDRX: 26.58 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MDRX' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -74.39  Med: 51.26 Max: 172.68
Current: 26.58
-74.39
172.68
3-Year Revenue Growth Rate 2.40
MDRX's 3-Year Revenue Growth Rate is ranked lower than
71% of the 1447 Companies
in the Global Software - Application industry.

( Industry Median: 5.30 vs. MDRX: 2.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MDRX' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -28.6  Med: 8.9 Max: 24.3
Current: 2.4
-28.6
24.3
3-Year EBITDA Growth Rate 62.60
MDRX's 3-Year EBITDA Growth Rate is ranked lower than
56% of the 1199 Companies
in the Global Software - Application industry.

( Industry Median: 8.40 vs. MDRX: 62.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
MDRX' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -68.8  Med: 7.45 Max: 105.4
Current: 62.6
-68.8
105.4
3-Year EPS without NRI Growth Rate -38.10
MDRX's 3-Year EPS without NRI Growth Rate is ranked lower than
99.99% of the 1094 Companies
in the Global Software - Application industry.

( Industry Median: 8.20 vs. MDRX: -38.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
MDRX' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -61.2  Med: 0 Max: 88.2
Current: -38.1
-61.2
88.2
GuruFocus has detected 2 Warning Signs with Allscripts Healthcare Solutions Inc $MDRX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MDRX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

MDRX Guru Trades in Q1 2016

First Eagle Investment 5,963,023 sh (+15.44%)
Chuck Royce 1,643,400 sh (+0.31%)
Michael Price 477,500 sh (unchged)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Jim Simons Sold Out
RS Investment Management 2,866,712 sh (-19.40%)
Third Avenue Management 204,351 sh (-31.32%)
Joel Greenblatt 160,157 sh (-89.18%)
» More
Q2 2016

MDRX Guru Trades in Q2 2016

Paul Tudor Jones 36,902 sh (New)
Jim Simons 251,865 sh (New)
Joel Greenblatt 186,620 sh (+16.52%)
Chuck Royce 1,666,900 sh (+1.43%)
Third Avenue Management 204,351 sh (unchged)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Michael Price 477,500 sh (unchged)
RS Investment Management 2,864,495 sh (-0.08%)
First Eagle Investment 4,774,073 sh (-19.94%)
» More
Q3 2016

MDRX Guru Trades in Q3 2016

Steven Cohen 347,900 sh (New)
Jim Simons 698,465 sh (+177.32%)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Michael Price 477,500 sh (unchged)
Third Avenue Management 204,351 sh (unchged)
Joel Greenblatt Sold Out
Chuck Royce 1,645,400 sh (-1.29%)
First Eagle Investment 4,578,690 sh (-4.09%)
Paul Tudor Jones 16,800 sh (-54.47%)
» More
Q4 2016

MDRX Guru Trades in Q4 2016

George Soros 38,900 sh (New)
Paul Tudor Jones 22,900 sh (+36.31%)
Chuck Royce 1,859,600 sh (+13.02%)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Michael Price 477,500 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
Third Avenue Management 203,687 sh (-0.32%)
First Eagle Investment 4,105,150 sh (-10.34%)
» More
» Details

Insider Trades

Latest Guru Trades with MDRX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Software - Application    NAICS: 541519    SIC: 7373
Compare:NAS:CVLT, NYSE:LOCK, NAS:ACIW, NAS:STMP, NAS:MSTR, NAS:VRNT, NAS:CSOD, NYSE:HUBS, NAS:TIVO, NAS:SYNA, NAS:FEYE, NYSE:LXFT, OTCPK:KSFTF, NYSE:ZEN, NAS:EBIX, OTCPK:ISMAY, NAS:PCTY, NYSE:RNG, NAS:RP, NYSE:TWLO » details
Traded in other countries:AL21.Germany,
Allscripts Healthcare Solutions Inc is a provider of clinical, financial, connectivity and information solutions and related professional services that empower hospitals, physicians and post-acute organizations to deliver world-class outcomes.

Allscripts Healthcare Solutions Inc was founded in 1986. The Company provides clinical, financial, connectivity and information solutions and related professional services that empower hospitals, physicians and post-acute organizations to deliver world-class outcomes. The Company operates in three reportable segments: Clinical and Financial Solutions, Population Health. The Clinical and Financial Solutions segment includes its Acute, TouchWorks, Professional Practices, Payer and Life Sciences, and International strategic business units. These solutions include EHR-related software, financial and practice management software, related installation and training services, and electronic claims administration services. The Population Health segment includes its Performance and Care Logistics and Population Health strategic business units. The Company delivers solutions that provide physicians and other healthcare professionals with the data, information, insights, and connectivity required to transform health care by improving the quality and efficiency of patient care and to navigate the transition from fee-for-service to value-based care. It provides solutions for home care, hospice, skilled nursing, and other post-acute organizations. These range from a fully integrated EHR and financial management solution to referral management. The Company offers several types of solutions that are tailored towards different segments of the market in which it operates and which support healthcare delivery in every care setting. It also offers various add-ons to increase the functionality of its product offerings. The Company competes with AmazingCharts.com, Inc., Aprima Medical Software, athenahealth Inc., Cerner Corporation, Computer Programs and Systems Inc., CureMD Healthcare, Curaspan Health Group, eClinicalWorks LLC, Emdeon, Epic Systems Corporation, Evolent Health, GE Healthcare Technologies, GE Management Systems, Healthagen, Healthcatalysts, Homecare Homebase (now controlled by Hearst Corporation), IBM Corporation, Infor-Med Medical Information Systems Inc., McKesson Corporation, MEDHOST, Inc., Medical Information Technology, Inc. (Meditech), Midas+, NextTech Systems, Optum (a division of United HealthCare Corporation), PracticeFusion, Inc., Quadramed, Quality Systems, Inc., Quest Diagnostics, Roper Industries, T-System, The Trizetto Group, Inc., Vitera Healthcare Solutions, Wellcentive and Wellsoft Corporation.

Ratios

vs
industry
vs
history
Forward PE Ratio 19.31
MDRX's Forward PE Ratio is ranked higher than
63% of the 369 Companies
in the Global Software - Application industry.

( Industry Median: 22.57 vs. MDRX: 19.31 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
Price-to-Owner-Earnings 22.75
MDRX's Price-to-Owner-Earnings is ranked higher than
54% of the 757 Companies
in the Global Software - Application industry.

( Industry Median: 24.81 vs. MDRX: 22.75 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
MDRX' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.61  Med: 36.11 Max: 840
Current: 22.75
8.61
840
PB Ratio 1.67
MDRX's PB Ratio is ranked higher than
73% of the 2031 Companies
in the Global Software - Application industry.

( Industry Median: 3.08 vs. MDRX: 1.67 )
Ranked among companies with meaningful PB Ratio only.
MDRX' s PB Ratio Range Over the Past 10 Years
Min: 0.79  Med: 2.17 Max: 5.17
Current: 1.67
0.79
5.17
PS Ratio 1.46
MDRX's PS Ratio is ranked higher than
63% of the 2013 Companies
in the Global Software - Application industry.

( Industry Median: 2.47 vs. MDRX: 1.46 )
Ranked among companies with meaningful PS Ratio only.
MDRX' s PS Ratio Range Over the Past 10 Years
Min: 0.9  Med: 2.31 Max: 7.04
Current: 1.46
0.9
7.04
Price-to-Free-Cash-Flow 17.15
MDRX's Price-to-Free-Cash-Flow is ranked higher than
76% of the 780 Companies
in the Global Software - Application industry.

( Industry Median: 26.64 vs. MDRX: 17.15 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MDRX' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 10.06  Med: 37.59 Max: 2138.46
Current: 17.15
10.06
2138.46
Price-to-Operating-Cash-Flow 8.32
MDRX's Price-to-Operating-Cash-Flow is ranked higher than
83% of the 972 Companies
in the Global Software - Application industry.

( Industry Median: 18.99 vs. MDRX: 8.32 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MDRX' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.77  Med: 22.3 Max: 79.2
Current: 8.32
5.77
79.2
EV-to-EBIT 99.84
MDRX's EV-to-EBIT is ranked lower than
87% of the 1323 Companies
in the Global Software - Application industry.

( Industry Median: 18.17 vs. MDRX: 99.84 )
Ranked among companies with meaningful EV-to-EBIT only.
MDRX' s EV-to-EBIT Range Over the Past 10 Years
Min: -1965.5  Med: 36.3 Max: 540.1
Current: 99.84
-1965.5
540.1
EV-to-EBITDA 16.86
MDRX's EV-to-EBITDA is ranked lower than
56% of the 1447 Companies
in the Global Software - Application industry.

( Industry Median: 14.43 vs. MDRX: 16.86 )
Ranked among companies with meaningful EV-to-EBITDA only.
MDRX' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.1  Med: 23.2 Max: 83.8
Current: 16.86
7.1
83.8
Shiller PE Ratio 231.72
MDRX's Shiller PE Ratio is ranked lower than
97% of the 292 Companies
in the Global Software - Application industry.

( Industry Median: 38.39 vs. MDRX: 231.72 )
Ranked among companies with meaningful Shiller PE Ratio only.
MDRX' s Shiller PE Ratio Range Over the Past 10 Years
Min: 48  Med: 115.14 Max: 247.8
Current: 231.72
48
247.8
Current Ratio 0.91
MDRX's Current Ratio is ranked lower than
85% of the 1798 Companies
in the Global Software - Application industry.

( Industry Median: 1.97 vs. MDRX: 0.91 )
Ranked among companies with meaningful Current Ratio only.
MDRX' s Current Ratio Range Over the Past 10 Years
Min: 0.91  Med: 1.75 Max: 9.91
Current: 0.91
0.91
9.91
Quick Ratio 0.91
MDRX's Quick Ratio is ranked lower than
82% of the 1798 Companies
in the Global Software - Application industry.

( Industry Median: 1.80 vs. MDRX: 0.91 )
Ranked among companies with meaningful Quick Ratio only.
MDRX' s Quick Ratio Range Over the Past 10 Years
Min: 0.8  Med: 1.66 Max: 9.36
Current: 0.91
0.8
9.36
Days Sales Outstanding 94.23
MDRX's Days Sales Outstanding is ranked lower than
74% of the 1495 Companies
in the Global Software - Application industry.

( Industry Median: 67.15 vs. MDRX: 94.23 )
Ranked among companies with meaningful Days Sales Outstanding only.
MDRX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 76.24  Med: 90.35 Max: 105.33
Current: 94.23
76.24
105.33
Days Payable 38.72
MDRX's Days Payable is ranked lower than
52% of the 1326 Companies
in the Global Software - Application industry.

( Industry Median: 42.55 vs. MDRX: 38.72 )
Ranked among companies with meaningful Days Payable only.
MDRX' s Days Payable Range Over the Past 10 Years
Min: 19.32  Med: 30.68 Max: 52.37
Current: 38.72
19.32
52.37

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.40
MDRX's 3-Year Average Share Buyback Ratio is ranked lower than
55% of the 1144 Companies
in the Global Software - Application industry.

( Industry Median: -2.50 vs. MDRX: -1.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MDRX' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -102.2  Med: -9.9 Max: 1.8
Current: -1.4
-102.2
1.8

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 2.57
MDRX's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
74% of the 850 Companies
in the Global Software - Application industry.

( Industry Median: 2.03 vs. MDRX: 2.57 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MDRX' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.9  Med: 2.09 Max: 6.47
Current: 2.57
0.9
6.47
Price-to-Median-PS-Value 0.63
MDRX's Price-to-Median-PS-Value is ranked higher than
84% of the 1759 Companies
in the Global Software - Application industry.

( Industry Median: 1.10 vs. MDRX: 0.63 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MDRX' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.5  Med: 1.09 Max: 9.76
Current: 0.63
0.5
9.76
Earnings Yield (Greenblatt) % 1.00
MDRX's Earnings Yield (Greenblatt) % is ranked lower than
54% of the 2127 Companies
in the Global Software - Application industry.

( Industry Median: 2.10 vs. MDRX: 1.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MDRX' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.2  Med: 2.2 Max: 5.9
Current: 1
0.2
5.9
Forward Rate of Return (Yacktman) % 4.80
MDRX's Forward Rate of Return (Yacktman) % is ranked lower than
73% of the 772 Companies
in the Global Software - Application industry.

( Industry Median: 10.37 vs. MDRX: 4.80 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MDRX' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -12.5  Med: 2.7 Max: 69.6
Current: 4.8
-12.5
69.6

More Statistics

Revenue (TTM) (Mil) $1,550
EPS (TTM) $ -0.14
Beta1.23
Short Percentage of Float10.35%
52-Week Range $9.80 - 15.17
Shares Outstanding (Mil)185.09

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 1,685 1,806 1,881
EPS ($) 0.65 0.70 0.79
EPS without NRI ($) 0.65 0.70 0.79
EPS Growth Rate
(Future 3Y To 5Y Estimate)
19.14%
Dividends per Share ($)
» More Articles for MDRX

Headlines

Articles On GuruFocus.com
The Moat Stays Strong, Even If the Listing Is Gone Oct 24 2016 
Companies Fall to 5-Year Lows Jun 22 2016 
Third Avenue Cuts Stake in Powell, BlackRock Dec 29 2015 
First Eagle Investment Buys 19 Stakes in Second Quarter Aug 17 2015 
Columbia Management's Top 5 New Buys Amid Buoyant Outlook Aug 12 2013 
Weekly CEO Buys Highlight: AKAM, DRC, MDRX, MTG, CDXS Mar 17 2013 
American Insider Trades: March 8-15 Mar 15 2013 
The Barclays Triggers More Insider Buying Mar 13 2013 
Allscripts-Misys Reports 5 Insider Buys the Day Before Barclays Conference Mar 13 2013 
Edward Owens’ 3 Biggest Stock Increases Feb 05 2013 

More From Other Websites
Allscripts Healthcare Solutions, Inc. :MDRX-US: Earnings Analysis: 2016 By the Numbers : February... Feb 22 2017
Allscripts Healthcare Solutions, Inc. :MDRX-US: Earnings Analysis: Q4, 2016 By the Numbers :... Feb 21 2017
2bPrecise Announces General Availability of Precision Medicine Platform Feb 20 2017
Allscripts (MDRX) Q4 Earnings Miss Estimates, View Upbeat Feb 17 2017
Edited Transcript of MDRX earnings conference call or presentation 16-Feb-17 9:30pm GMT Feb 16 2017
AllScripts reports 4Q loss Feb 16 2017
AllScripts reports 4Q loss Feb 16 2017
[$$] Allscripts Revenue Rises on Netsmart Acquisition Feb 16 2017
Allscripts Healthcare Solutions Inc Earnings Call scheduled for 4:30 pm ET today Feb 16 2017
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Files SEC form 8-K, Results of Operations and Financial... Feb 16 2017
Allscripts announces fourth quarter and 2016 full-year results Feb 16 2017
Q4 2016 Allscripts Healthcare Solutions Inc Earnings Release - After Market Close Feb 16 2017
MedTech Stocks' Q4 Earnings on Feb 16: LH, WST and MDRX Feb 15 2017
Can Allscripts (MDRX) Surprise Investors in Q4 Earnings? Feb 10 2017
4 Healthcare Players Likey to Trump Q4 Earnings Estimates Feb 06 2017
Black Book Rankings™ names Allscripts top core EHR with a population health management solution Feb 01 2017
Allscripts open ecosystem enables more than 2 billion data shares, continues to lead industry in... Jan 30 2017
ETFs with exposure to Allscripts Healthcare Solutions, Inc. : January 19, 2017 Jan 19 2017
Allscripts expands leadership team; heightening focus on client support, international growth Jan 19 2017
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Files SEC form 8-K/A, Financial Statements and Exhibits Jan 11 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)